FindTrial
Sign In

Retrospective study on immune status monitoring and infection risk assessment during immunosuppressive therapy for lupus nephritis

Retrospective study on immune status monitoring and infection risk assessment during immunosuppressive therapy for lupus nephritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030510
Enrollment
Unknown
Registered
2020-03-05
Start date
2020-03-04
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus nephritis

Interventions

Infection group:antibiotic therapy
un-infection grou:No antibiotic treatment

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with diagnosis of lupus nephritis and got immunosuppressive therapy; aged 14-80 years.

Exclusion criteria

Exclusion criteria: Patients with severe infection have appeared before the treatment of immunosuppression in our department Those who have stopped hormone or other immunosuppressants; Pregnant woman.

Design outcomes

Primary

MeasureTime frame
Age;Gender;Date;Therapeutic schedule;Routine blood test;Routine urine test;24-hour urine protein quantification;Liver function;Renal function;Complement C3;Complement C4;Lymphocyte subsets;Autoantibody;Antinuclear antibody;PCT;IL-6;Renal pathology report;SLEDAI score;Immunosuppressive therapeutic schedule;Antibiotic;—

Countries

Chnia

Contacts

Public ContactYi Li

the First Affiliated Hospital of Army Medical University,PLA

94086002@qq.com+86 13627666360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026